why choose us

CME Courses

Showing 60 of 3,966 result(s)
Course: Case Studies in Diagnosing and Managing FOP

Description: This program, led by Christiaan Scott, MD, Professor of Pediatric Rheumatology at the University of Ottawa and Raphaella Stander, ...

CME Credit: 0.00

Course: Compassionate Communication in HIV Care: Sharing Test Results and Guiding Patients Toward Treatment

Description: Primary care clinicians play a vital role in engaging and retaining patients living with HIV in care. The need is especially great...

CME Credit: 0.25

Course: Supporting Individuals With HIV: Addressing Common Treatment Barriers and Expanding Access to Resources

Description: After an HIV diagnosis, primary care clinicians are essential in providing support and guiding patients as they begin treatment. I...

CME Credit: 0.25

Course: Race, Ethnicity, and Pulmonary Function Test Interpretation

Description: A shift toward race-neutral pulmonary function test (PFT) interpretation is underway. This activity breaks down the ATS’ officia...

CME Credit: 0.00

Course: Bladder Cancer Care: First-Line mUC Strategies in Practice

Description: In recent years, treatment options for bladder cancer have rapidly advanced. The 2024 NCCN Guidelines outline new first-line thera...

CME Credit: 1.00

Course: The Evolving Landscape of Anemia in MDS & MPN: Clinical Updates and Best Practices

Description: The Evolving Landscape of Anemia in MDS & MPN: Clinical Updates and Best Practices targets global hematology/oncology clinicians w...

CME Credit: 1.00

Course: Optimizing Bispecific Antibody Treatment for Non-Hodgkin Lymphoma: Current Best Practices for Mitigating and Managing Cytokine Release Syndrome

Description: The goal of this educational activity is to equip and empower oncology pharmacists, nurse practitioners (NPs), and nurses with the...

CME Credit: 1.00

Course: Addressing Adverse Events Associated With Bispecific Antibody Therapies: Managing Care for Patients in Rural and Underserved Communities

Description: Therapy options using bispecific antibodies (BsAbs) are rapidly expanding and driving improved outcomes across a range of cancers,...

CME Credit: 0.00

Course: Evolving Treatment Approaches for Relapsed and Refractory Multiple Myeloma: Integrating the Latest Evidence Into the Care of Patients in Rural and Underserved Communities

Description: Over the past two decades, treatment advancements in multiple myeloma—including proteasome inhibitors, immunomodulatory drugs, a...

CME Credit: 0.00